These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 18703366
21. [Efficacy and safety of a phenylalanine-free amino acid-based enteral formula (AA-PKU2) in 1-8 year-old children with phenylketonuria: a prospective, open, self-controlled and multi-center study in China]. Zhou XL, Zhao ZY, Jiang JH, Zou H, Gu XF, Gu Q, Shen M, Lu J. Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):11-5. PubMed ID: 24461170 [Abstract] [Full Text] [Related]
23. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels. Sharman R, Sullivan K, Young R, McGill J. Dev Neuropsychol; 2010 Jan; 35(1):57-65. PubMed ID: 20390592 [Abstract] [Full Text] [Related]
26. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life. Waisbren SE, Mahon BE, Schnell RR, Levy HL. Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635 [Abstract] [Full Text] [Related]
28. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J. Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065 [Abstract] [Full Text] [Related]
29. Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria. Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, van Spronsen FJ. J Pediatr; 2014 Apr; 164(4):895-899.e2. PubMed ID: 24485821 [Abstract] [Full Text] [Related]
30. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study. Jahja R, van Spronsen FJ, de Sonneville LMJ, van der Meere JJ, Bosch AM, Hollak CEM, Rubio-Gozalbo ME, Brouwers MCGJ, Hofstede FC, de Vries MC, Janssen MCH, van der Ploeg AT, Langendonk JG, Huijbregts SCJ. J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933 [Abstract] [Full Text] [Related]
33. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)]. Knoll E, Wehle E, Thalhammer O. Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401 [Abstract] [Full Text] [Related]
34. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes. Cleary M, Trefz F, Muntau AC, Feillet F, van Spronsen FJ, Burlina A, Bélanger-Quintana A, Giżewska M, Gasteyger C, Bettiol E, Blau N, MacDonald A. Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706 [Abstract] [Full Text] [Related]
36. Plasma cholesterol in adults with phenylketonuria. Williams RA, Hooper AJ, Bell DA, Mamotte CD, Burnett JR. Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302 [Abstract] [Full Text] [Related]